CP and cancer: Dysfunction in the UPS is associated with various diseases, as reviewed inrefs 4, 5, with hyperactivationof proteasome function often invoked by cancer cells4, 6, 7 andinhibitors specifically targeting the CP (bortezomib, carfilzomib and ixazomib) usedclinically to treat haematological cancers8, 9, 10.